{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:08:21Z","timestamp":1784354901341,"version":"3.55.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.urology.2005.07.063","type":"journal-article","created":{"date-parts":[[2006,1,7]],"date-time":"2006-01-07T12:21:42Z","timestamp":1136636502000},"page":"75-89","source":"Crossref","is-referenced-by-count":36,"special_numbering":"S1","title":["Low-grade Ta (noninvasive) urothelial carcinoma of the bladder"],"prefix":"10.1016","volume":"66","author":[{"given":"Willem","family":"Oosterlinck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Solsona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Akaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Goebell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Uno","family":"Malmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haluk","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sved","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2005.07.063_bib1","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)66443-9","article-title":"Stage progression in Ta papillary urothelial tumors","volume":"165","author":"Holm\u00e4ng","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib1a","first-page":"10","article-title":"Evidence-based medicine","volume":"Volume 1","author":"Abrams","year":"2005"},{"key":"10.1016\/j.urology.2005.07.063_bib2","series-title":"Classification of Malignant Tumors","author":"Sobin","year":"2002"},{"key":"10.1016\/j.urology.2005.07.063_bib3","series-title":"World Health Organization Classification of Tumors. Pathology and Genetics Tumours of the Urinary System and Male Genital Organs","article-title":"Non-invasive urothelial neoplasias. WHO classification of non invasive papillary urothelial neoplasias. WHO Classification of non invasive papillary urothelial tumors","author":"Sauter","year":"2004"},{"issue":"suppl 6A","key":"10.1016\/j.urology.2005.07.063_bib4","article-title":"Bladder cancer","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.07.063_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1464-410X.2003.04415.x","article-title":"Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential","volume":"92","author":"Fujii","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2005.07.063_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1464-4096.2001.02396.x","article-title":"Does cystoscopy correlate with the histology of recurrent papillary tumors of the bladder?","volume":"88","author":"Herr","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2005.07.063_bib7","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0022-5347(05)64555-7","article-title":"Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder","volume":"168","author":"Herr","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000474652","article-title":"A plea for cold biopsy, fulguration and immediate bladder instillation with epirubicin in small superficial bladder tumors","volume":"23","author":"Oosterlinck","year":"1993","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1053\/hupa.2001.24999","article-title":"Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder","volume":"32","author":"Cina","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urology.2005.07.063_bib10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0022-5347(01)65180-2","article-title":"Is routine excretory urography necessary at first diagnosis of bladder cancer?","volume":"157","author":"Goessl","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000068001","article-title":"Need for intravenous urography in patients with primary transitional carcinoma of the bladder?","volume":"36","author":"Herranz-Amo","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib12","first-page":"782","article-title":"Transitional carcinomas of the urinary tract","volume":"18","author":"Arrizabalaga","year":"1994","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.urology.2005.07.063_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1148\/radiology.167.3.3363119","article-title":"Synchronous and metachronous transitional cell carcinoma of the urinary tract","volume":"167","author":"Yousem","year":"1988","journal-title":"Radiology"},{"key":"10.1016\/j.urology.2005.07.063_bib14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0022-5347(17)41291-2","article-title":"Carcinoma of the renal pelvis and ureter following bladder carcinoma","volume":"141","author":"Oldbring","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000474814","article-title":"Upper tract urothelial tumor after transurethral resection for bladder tumor","volume":"21","author":"Palou","year":"1992","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0090-4295(96)00571-7","article-title":"Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis)","volume":"49","author":"Solsona","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.07.063_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0022-5347(17)51395-6","article-title":"Should followup of patients with bladder cancer include routine excretory urography?","volume":"130","author":"Walzer","year":"1983","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-5347(01)63024-6","article-title":"Long-term follow-up of a bladder carcinoma cohort","volume":"160","author":"Holm\u00e4ng","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0090-4295(89)90370-1","article-title":"Routine excretory urography on follow-up in superficial transitional cell carcinoma of bladder","volume":"34","author":"Smith","year":"1989","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.07.063_bib20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0022-5347(17)49028-8","article-title":"Upper urinary tract transitional cell carcinoma in patients with bladder carcinoma and associated vesicoureteral reflux","volume":"133","author":"Amar","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-5347(17)42984-3","article-title":"Vesicorenal reflux and upper urinary tract transitional cell carcinoma after transurethral resection of recurrence superficial bladder carcinoma","volume":"138","author":"De Torres","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1200\/JCO.2001.19.1.94","article-title":"Upper-tract tumors after an initial diagnosis of bladder cancer","volume":"19","author":"Rabbani","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2005.07.063_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0090-4295(93)90329-9","article-title":"Upper tract transitional cell carcinoma following treatment of superficial bladder cancer with BCG","volume":"42","author":"Miller","year":"1993","journal-title":"Urology"},{"issue":"suppl","key":"10.1016\/j.urology.2005.07.063_bib24","first-page":"273A","article-title":"Upper tract disease following intravesical BCG for superficial bladder cancer","volume":"147","author":"Schwalb","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0090-4295(92)90404-K","article-title":"Urothelial tumors of upper tract following treatment of primary bladder transitional cell carcinoma","volume":"40","author":"Schwartz","year":"1992","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.07.063_bib26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-5347(17)43123-5","article-title":"Ureteral carcinoma in situ after successful intravesical therapy for superficial bladder tumors","volume":"138","author":"Herr","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib27","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0090-4295(99)00002-3","article-title":"Upper urinary tract tumor developing after treatment of superficial bladder cancer","volume":"53","author":"Hurle","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.07.063_bib28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0022-5347(05)67137-6","article-title":"Upper urinary tract tumors after primary superficial bladder tumors","volume":"164","author":"Millan","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1442-2042.2003.00611.x","article-title":"Value of selective upper tract cytology for recognition of upper tract tumor after treatment of superficial bladder cancer","volume":"10","author":"Gogus","year":"2003","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-5347(01)62068-8","article-title":"The value of upper tract cytology after transurethral resection of bladder tumor in patients with transitional cell cancer","volume":"161","author":"Sadek","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib31","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0022-5347(01)65570-8","article-title":"Upper tract tumors in patients with primary bladder cancer followed for 15 years","volume":"156","author":"Herr","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0022-5347(01)66338-9","article-title":"Extravesical involvement in patients with bladder carcinoma in situ","volume":"155","author":"Solsona","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eururo.2004.04.011","article-title":"EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma","volume":"46","author":"Oosterlinck","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000019859","article-title":"Significance of bladder biopsies in Ta, T1 bladder tumors","volume":"135","author":"van der Meijden","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00208916","article-title":"Random biopsies and the risk of recurrent superficial bladder cancer","volume":"10","author":"Witjes","year":"1992","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib36","first-page":"785","article-title":"Significance of random biopsies of healthy mucosa in superficial bladder tumor","volume":"53","author":"Fernandez Gomez","year":"2000","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib37","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0022-5347(17)36198-0","article-title":"A prospective EORTC-GU Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder","volume":"149","author":"Oosterlinck","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0302-2838(03)00157-X","article-title":"Significance of random bladder biopsies in superficial bladder cancer","volume":"44","author":"May","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib39","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/1097-0142(19800901)46:5<1158::AID-CNCR2820460514>3.0.CO;2-E","article-title":"Urothelial susceptibility to tumor cell implantation influence of cauterization","volume":"46","author":"Soloway","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2005.07.063_bib40","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0022-5347(17)39174-7","article-title":"Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder","volume":"142","author":"Pan","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1464-410X.1976.tb02742.x","article-title":"Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma","volume":"48","author":"Burnand","year":"1976","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib42","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-5347(17)57202-X","article-title":"Intravesical thiotepa in the immediate post-operative period in patients with recurrent transitional cell carcinoma of the bladder","volume":"120","author":"Garrett","year":"1978","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib43","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/0090-4295(75)90367-2","article-title":"Susceptibility of urothelium to neoplastic cellular implantation","volume":"5","author":"Weldon","year":"1975","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.07.063_bib44","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1464-410X.1981.tb03266.x","article-title":"A controlled trial of single dose intravesical adriamycin in superficial bladder tumors","volume":"53","author":"Abrams","year":"1981","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00326750","article-title":"Single dose intravesical epodyl after TUR of Ta TCC bladder carcinoma","volume":"1","author":"Kurth","year":"1983","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib46","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1464-410X.1985.tb07031.x","article-title":"The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer","volume":"57","year":"1985","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib47","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1464-410X.1994.tb07547.x","article-title":"The effect of intravesical thiotepa on tumor recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer","volume":"73","year":"1994","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib48","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1464-410X.1997.00142.x","article-title":"Single dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional cell bladder tumors","volume":"79","author":"Ali-el-Dein","year":"1997","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib49","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-5347(01)61606-9","article-title":"Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer","volume":"161","author":"Solsona","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib50","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0022-5347(01)61609-4","article-title":"Transurethral resection with perioperative instillation of interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer","volume":"161","author":"Rajala","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib51","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0022-5347(05)64556-9","article-title":"Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence","volume":"168","author":"Rajala","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib52","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/cncr.10496","article-title":"Randomized study of single early instillation of (2\u2032\u2032R)-4\u2032-O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma","volume":"94","author":"Okamura","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2005.07.063_bib53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0302-2838(01)00026-4","article-title":"Guidelines on bladder cancer","volume":"41","author":"Oosterlinck","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib54","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1097\/01.ju.0000125486.92260.b2","article-title":"A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer","volume":"171","author":"Sylvester","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-5347(17)52205-3","article-title":"Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence","volume":"129","author":"Zincke","year":"1983","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib56","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1136\/bmj.296.6639.1759","article-title":"Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer","volume":"1296","author":"Tolley","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.urology.2005.07.063_bib57","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0022-5347(01)66226-8","article-title":"The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer","volume":"155","author":"Tolley","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib58","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0302-2838(02)00068-4","article-title":"Variability in the recurrence rate at first follow up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder","volume":"41","author":"Brausi","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib59","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0022-5347(05)68935-5","article-title":"Intravesical chemotherapy with epirubicin","volume":"161","author":"Masters","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib60","first-page":"142","article-title":"Preliminary results of a MRC randomised controlled trial of post-operative irrigation of superficial bladder cancer","volume":"20","author":"Whelan","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.urology.2005.07.063_bib61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0302-2838(02)00260-9","article-title":"Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma","volume":"42","author":"Kaasinen","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib62","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0022-5347(01)67608-0","article-title":"Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma","volume":"153","author":"Bouffioux","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib63","first-page":"1001","article-title":"Results of a randomized, double-blind prospective study of intravesical chemoprophylaxis with 2 drugs, adriamycin and mitomycin, and 2 ways of initiating the instillations, early and late","volume":"45","author":"Iborra","year":"1992","journal-title":"Arch Esp de Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib64","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1046\/j.1464-410x.1999.00951.x","article-title":"Perivesical fat necrosis after adjuvant intravesical chemotherapy","volume":"83","author":"Doherty","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2005.07.063_bib65","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0302-2838(03)00151-9","article-title":"Unusual complication after immediate postoperative intravesical mitomycin C instillation","volume":"43","author":"Nieuwenhuijzen","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib66","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000067698","article-title":"Distal ureteral stenosis after early adjuvant intravesical mitomycin C application for superficial bladder cancer","volume":"70","author":"Oehlschlager","year":"2003","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2005.07.063_bib67","first-page":"459","article-title":"Bone marrow suppression after intravesical mitomycin C treatment","volume":"13","author":"Tawkif","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib68","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1818::AID-CNCR25>3.0.CO;2-0","article-title":"Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection","volume":"86","author":"Hinotsu","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2005.07.063_bib69","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0022-5347(17)40002-4","article-title":"Bacillus Calmette-Gu\u00e9rin versus doxorubicin versus thiotepa","volume":"143","author":"Martinez-Pi\u00f1eiro","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib70","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000473519","article-title":"Prophylactic chemotherapy of superficial bladder transitional cell bladder carcinoma","volume":"8","author":"Schulman","year":"1982","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib71","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0022-5347(17)49582-6","article-title":"Adjuvant chemotherapy of superficial transitional cell bladder carcinoma","volume":"132","author":"Kurth","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib72","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-5347(05)68208-0","article-title":"Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS)","volume":"162","author":"Smith","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib73","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00280-002-0487-6","article-title":"Intravesical adjuvant chemotherapy for superficial transitional Bladder Cancer","volume":"50","author":"Nomata","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.urology.2005.07.063_bib74","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.ju.0000100386.07370.0a","article-title":"A randomised controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta\/T1 transitional cell carcinoma of the bladder","volume":"171","author":"Kogaa","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib75","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/93.8.597","article-title":"Methods to improve efficacy of intravesical mitomycin C","volume":"93","author":"Au","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2005.07.063_bib76","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0094-0143(21)00424-9","article-title":"Long-term results of intravesical therapy for superficial bladder cancer","volume":"19","author":"Lamm","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urology.2005.07.063_bib77","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/01.COC.0000026911.98171.C6","article-title":"Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder","volume":"26","author":"Huncharek","year":"2003","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.urology.2005.07.063_bib78","first-page":"CD003231","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin in Ta and T1 bladder cancer","author":"Shelley","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.urology.2005.07.063_bib79","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-5347(05)64043-8","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin versus mitomycin C for superficial bladder cancer","volume":"169","author":"B\u00f6lhe","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib80","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin reduces the risk of progression in patients with superficial bladder cancer","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib81","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1464-410x.1999.00078.x","article-title":"The long-term outcome in patients with superficial transitional cell carcinoma of the bladder","volume":"83","author":"Haukaas","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2005.07.063_bib82","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-5347(05)67280-1","article-title":"Primary superficial bladder cancer risk groups according to progression, mortality and recurrence","volume":"164","author":"Millan","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib83","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1464-410x.2000.00547.x","article-title":"Long-term follow-up of noninvasive bladder tumors (stage Ta)","volume":"85","author":"Zieger","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2005.07.063_bib84","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0022-5347(17)52330-7","article-title":"Prognostic factors in superficial bladder tumors","volume":"129","author":"Dalesio","year":"1983","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib85","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1464-410X.2003.04360.x","article-title":"Superficial bladder tumors analysis of prognostic factors and construction of a predictive index","volume":"92","author":"Ali-El-Dein","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2005.07.063_bib86","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1464-410x.1998.00628.x","article-title":"The early clinical course of primary Ta and T1 bladder cancer","volume":"81","author":"Allard","year":"1998","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2005.07.063_bib87","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0022-5347(17)36924-0","article-title":"Treated history of noninvasive grade 1 transitional cell carcinoma","volume":"148","author":"Prout","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib88","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0022-5347(17)38731-1","article-title":"Prognostic factors for recurrence and follow-up policies in the treatment of superficial bladder cancer","volume":"142","author":"Parmar","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib89","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/00365590310008037","article-title":"A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years","volume":"37","author":"Larsson","year":"2003","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.urology.2005.07.063_bib90","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0022-5347(17)45923-4","article-title":"Superficial bladder tumors","volume":"135","author":"Fitzpatrick","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib91","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-5347(05)67975-X","article-title":"Multivariate analysis of the prognostic risk factors of primary superficial bladder cancer","volume":"163","author":"Millan-Rodriguez","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib92","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/S0022-5347(05)68075-5","article-title":"Long-term follow-up of initial Ta grade 1 transitional cell carcinoma of the bladder","volume":"162","author":"Leblanc","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib93","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1097\/01.ju.0000067160.09881.45","article-title":"Grade progression and regression in recurrent urothelial cancer","volume":"169","author":"Borhan","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib94","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.ju.0000076621.71247.6c","article-title":"Expectant management of small recurrent, non-invasive papillary bladder tumors","volume":"170","author":"Soloway","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib95","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000052355","article-title":"Proposal for changes in cystoscopic follow-up of patients with low-grade pTa bladder tumor","volume":"37","author":"Oge","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib96","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0022-5347(17)39742-2","article-title":"Outpatient flexible cystoscopy and fulguration of recurrent superficial bladder tumors","volume":"144","author":"Herr","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.07.063_bib97","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/01.ju.0000103100.22951.5e","article-title":"Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm","volume":"171","author":"Donat","year":"2004","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429505014949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429505014949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T09:41:58Z","timestamp":1626946918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429505014949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0090429505014949"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2005.07.063","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}